Related Experiment Videos
[Anti-tumor immune response against mouse melanoma to xenogeneic vaccination]
1Center of Cancer Biotherapy, First Affiliated Hospital, West China University of Medical Sciences, Chengdu 610041, China.
Objective:
To study the inhibition of melanoma growth in mice by vaccination with xenogeneic melanocytes.
Methods:
Xenogeneic vaccine was prepared from pig eye melanocytes. It was used before or after B16 melanoma challenge in C57 mice. The size of tumor was monitored. Cytotoxic T lymphocyte (CTL) activity of mouse spleen cells was measured by 51Cr release assay. Antibody response against pig melanocytes and B16 melanoma cells were detected by indirect ELISA.
Results:
Preventive vaccination resulted in inhibition of tumor growth in 90% of the immunized mice, while therapeutic vaccination inhibited tumor growth in 50% of the treated mice. Specific CTL activity and antibodies in the immunized mice were detected.
Conclusion:
Anti-tumor immune response capable of inhibiting melanoma growth can be induced by xenogeneic melanocyte vaccination.
Insights
Xenogeneic melanocyte vaccination effectively inhibited melanoma growth in mice. This approach induced anti-tumor immune responses, showing promise for melanoma treatment strategies.
Area of Science:
- Immunology
- Oncology
- Xenotransplantation
Context:
- Melanoma is an aggressive skin cancer with limited treatment options.
- Developing effective anti-tumor vaccines is a critical area of cancer research.
- Xenogeneic vaccines present a potential strategy for inducing anti-cancer immunity.
Purpose:
- To investigate the efficacy of xenogeneic melanocyte vaccination in inhibiting melanoma growth in a mouse model.
- To evaluate both preventive and therapeutic vaccination strategies.
- To assess the immune responses, including cytotoxic T lymphocyte (CTL) activity and antibody production, elicited by the vaccine.
Summary:
- A vaccine was prepared using pig eye melanocytes and administered to C57 mice before or after B16 melanoma challenge.
- Preventive vaccination led to tumor growth inhibition in 90% of mice, while therapeutic vaccination achieved 50% inhibition.
- The study detected specific CTL activity and antibodies against both pig melanocytes and B16 melanoma cells in immunized mice.
Impact:
- Xenogeneic melanocyte vaccination can induce a potent anti-tumor immune response.
- This vaccination strategy demonstrates significant potential for controlling melanoma progression.
- The findings support further exploration of xenogeneic cell-based vaccines in cancer immunotherapy.